Adaptive Biotechnologies Corp Forecast, price target & analysts
Adaptive Biotechnologies Corp Target price 2025 - Analyst rating & recommendation
Adaptive Biotechnologies Corp Classifications & Recommendation:
Adaptive Biotechnologies Corp Price Target
| Target Price | $12.75 |
| Price | $11.79 |
| Potential |
8.14%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Adaptive Biotechnologies Corp 2026 .
The average Adaptive Biotechnologies Corp target price is $12.75.
This is
8.14%
register free of charge
$15.75
33.59%
register free of charge
$9.09
22.90%
register free of charge
|
|
| A rating was issued by 14 analysts: 12 Analysts recommend Adaptive Biotechnologies Corp to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Adaptive Biotechnologies Corp stock has an average upside potential 2026 of
8.14%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 178.96 | 222.73 |
| 5.10% | 24.46% | |
| EBITDA Margin | -81.03% | -29.78% |
| 26.38% | 63.25% | |
| Net Margin | -89.12% | -59.04% |
| 32.63% | 33.75% |
9 Analysts have issued a sales forecast Adaptive Biotechnologies Corp 2025 . The average Adaptive Biotechnologies Corp sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Adaptive Biotechnologies Corp EBITDA forecast 2025. The average Adaptive Biotechnologies Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Adaptive Biotechnologies Corp Analysts have issued a net profit forecast 2025. The average Adaptive Biotechnologies Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.08 | -0.87 |
| 30.77% | 19.44% | |
| P/E | negative | |
| EV/Sales | 7.77 |
9 Analysts have issued a Adaptive Biotechnologies Corp forecast for earnings per share. The average Adaptive Biotechnologies Corp EPS is
This results in the following potential growth metrics and future valuations:
Adaptive Biotechnologies Corp...
Current Adaptive Biotechnologies Corp Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Jun 18 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | May 05 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | May 02 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Scotiabank |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Jun 18 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 05 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 02 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
Scotiabank:
Locked
➜
Locked
|
Feb 13 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
